 Connection
David Wagner to Peptides
This is a "connection" page, showing publications David Wagner has written about Peptides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.508 |
|
|
|
-
Vaitaitis GM, Waid DM, Sharkey C, Sharkey S, Webb TL, Webb C, Wagner DH. A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomes. Front Immunol. 2026; 17:1759373.
Score: 0.622
-
Vaitaitis GM, Wagner DH. Modulating CD40 and integrin signaling in the proinflammatory nexus using a 15-amino-acid peptide, KGYY15. J Biol Chem. 2023 05; 299(5):104625.
Score: 0.508
-
Vaitaitis GM, Olmstead MH, Waid DM, Carter JR, Wagner DH. A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice. Diabetologia. 2014 Nov; 57(11):2366-73.
Score: 0.280
-
Vaitaitis GM, Olmstead MH, Waid DM, Carter JR, Wagner DH. CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter]. Diabetologia. 2019 09; 62(9):1730-1731.
Score: 0.098
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|